과제정보
연구 과제 주관 기관 : Chiang Mai University
참고문헌
- Abbas A, Medvedev S, Shores N, et al (2014). Epidemiology of metastatic hepatocellular carcinoma, a nationwide perspective. Dig Dis Sci, 59, 2813-20. https://doi.org/10.1007/s10620-014-3229-9
- Bae HM, Lee SH, Kim TM, et al (2012). Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis. Lung Cancer, 77, 572-7. https://doi.org/10.1016/j.lungcan.2012.05.094
- Coleman RE (2001). Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev, 27, 165-76. https://doi.org/10.1053/ctrv.2000.0210
- Coleman RE (2006). Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res, 12, 6243s-9s. https://doi.org/10.1158/1078-0432.CCR-06-0931
- D'Addario G, Fruh M, Reck M, et al (2010). Metastatic nonsmall-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 21, 116-9. https://doi.org/10.1093/annonc/mdq189
- Goodwin CR, Abu-Bonsrah N, Boone C, et al (2016). Nonhepatocellular carcinoma spinal metastases. J Clin Neurosci, 27, 22-7. https://doi.org/10.1016/j.jocn.2015.11.003
- Habermehl D, Haase K, Rieken S, et al (2011). Defining the role of palliative radiotherapy in bone metastasis from primary liver cancer: an analysis of survival and treatment efficacy. Tumori, 97, 609-13. https://doi.org/10.1177/030089161109700512
- Ibrahim T, Mercatali L, Amadori D (2013). A new emergency in oncology: Bone metastases in breast cancer patients (Review). Oncol Lett, 6, 306-10. https://doi.org/10.3892/ol.2013.1372
- Katayose Y, Nakagawa K, Yamamoto K, et al (2012). Lymph nodes metastasis is a risk factor for bone metastasis from extrahepatic cholangiocarcinoma. Hepatogastroenterol, 59, 1758-60.
- Khuntikeo N, Chamadol N, Yongvanit P, et al (2015). Cohort profile: cholangiocarcinoma screening and care program (CASCAP). BMC Cancer, 15, 459. https://doi.org/10.1186/s12885-015-1475-7
- Kim SU, Kim DY, Park JY, et al (2008). Hepatocellular carcinoma presenting with bone metastasis: clinical characteristics and prognostic factors. J Cancer Res Clin Oncol, 134, 1377-84. https://doi.org/10.1007/s00432-008-0410-6
- Li S, Peng Y, Weinhandl ED, et al (2012). Estimated number of prevalent cases of metastatic bone disease in the US adult population. Clin Epidemiol, 4, 87-93.
- Liede A, Jerzak KJ, Hernandez RK, et al (2016). The incidence of bone metastasis after early-stage breast cancer in Canada. Breast Cancer Res Treat, 156, 587-95. https://doi.org/10.1007/s10549-016-3782-3
- Makino H, Nishio S, Tsubamoto H, et al (2016). Treatment and prognosis of bone metastasis from cervical cancer (KCOGG1202s). J Obstet Gynaecol Res.
- McDougall JA, Bansal A, Goulart BH, et al (2016). The clinical and economic impacts of skeletal-related events among medicare enrollees with prostate cancer metastatic to bone. Oncologist, 21, 320-6. https://doi.org/10.1634/theoncologist.2015-0327
- Nguyen DX, Bos PD, Massague J (2009). Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer, 9, 274-84. https://doi.org/10.1038/nrc2622
- Oster G, Lamerato L, Glass AG, et al (2013). Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems. Support Care Cancer, 21, 3279-86. https://doi.org/10.1007/s00520-013-1887-3
- Paholpak P, Sirichativapee W, Wisanuyotin T, et al (2012). Prevalence of known and unknown primary tumor sites in spinal metastasis patients. Open Orthop J, 6, 440-4. https://doi.org/10.2174/1874325001206010440
- Qiu ZL, Song HJ, Xu YH, et al (2011). Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer. J Clin Endocrinol Metab, 96, 3078-86. https://doi.org/10.1210/jc.2011-0093
- Singh VA, Haseeb A, Alkubaisi AA (2014). Incidence and outcome of bone metastatic disease at University Malaya Medical Centre. Singapore Med J, 55, 539-46. https://doi.org/10.11622/smedj.2014138
- Sugino K, Kameyama K, Nagahama M, et al (2014). Follicular thyroid carcinoma with distant metastasis: outcome and prognostic factor. Endocr J, 61, 273-9. https://doi.org/10.1507/endocrj.EJ13-0437
- Takagi T, Katagiri H, Kim Y, et al (2015). Skeletal Metastasis of Unknown Primary Origin at the Initial Visit: A Retrospective Analysis of 286 Cases. PLoS One, 10, 129428.
- Tanaka R, Yonemori K, Hirakawa A, et al (2016). Risk factors for developing skeletal-related events in breast cancer patients with bone metastases undergoing treatment with bone-modifying agents. Oncologist, 21, 508-13. https://doi.org/10.1634/theoncologist.2015-0377
- Tarnoki DL, Tarnoki AD, Ohlmann-Knafo S, et al (2016). Pattern of Tumour Spread of Common Primary Tumours as Seen on Magnetic Resonance Imaging. Pathol Oncol Res, 22, 79-85. https://doi.org/10.1007/s12253-015-9975-y
- Thanapprapasr D, Nartthanarung A, Likittanasombut P, et al (2010). Bone metastasis in cervical cancer patients over a 10-year period. Int J Gynecol Cancer, 20, 373-8. https://doi.org/10.1111/IGC.0b013e3181d4a0a1
- Thunyaharn N, Promthet S, Wiangnon S, et al (2013). Survival of cholangiocarcinoma patients in northeastern Thailand after supportive treatment. Asian Pac J Cancer Prev, 14, 7029-32. https://doi.org/10.7314/APJCP.2012.14.11.7029
- Tomita K, Kawahara N, Kobayashi T, et al (2001). Surgical strategy for spinal metastases. Spine, 26, 298-306. https://doi.org/10.1097/00007632-200102010-00016
- Tsuya A, Kurata T, Tamura K, et al (2007). Skeletal metastases in non-small cell lung cancer: a retrospective study. Lung Cancer, 57, 229-32. https://doi.org/10.1016/j.lungcan.2007.03.013
- Uchino K, Tateishi R, Shiina S, et al (2011). Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. Cancer, 117, 4475-83. https://doi.org/10.1002/cncr.25960
- Zoccali C, Skoch J, Walter CM, et al (2016). The Tokuhashi score: effectiveness and pitfalls. Eur Spine J, 25, 673-8. https://doi.org/10.1007/s00586-015-4339-6